Elevated Potassium Levels in Patients With Congestive Heart Failure: Occurrence, Risk Factors, and Clinical Outcomes:...

Area of Science:

• Cardiology
• Nephrology
• Public Health

Background:

• Limited real-world data exists on the burden of hyperkalemia in heart failure (HF) patients.
• Hyperkalemia is a serious electrolyte imbalance that can complicate HF management.

Purpose of the Study:

• To assess the incidence, risk factors, and clinical outcomes of hyperkalemia in a large heart failure population.
• To understand the real-world burden and consequences of hyperkalemia in HF.

Main Methods:

• A population-based cohort study in northern Denmark (2000-2012) of 31,649 patients with incident heart failure.
• Analysis of hyperkalemia incidence, risk factors (CKD, diabetes, spironolactone), and outcomes (hospitalization, death).

Main Results:

• 39% of HF patients experienced hyperkalemia, with high recurrence rates (up to 60%).
• Chronic kidney disease, diabetes, and spironolactone use were key risk factors.
• Hyperkalemia was associated with a 2.75-fold increase in hospitalization and a 3.39-fold increase in death risk.

Conclusions:

• Hyperkalemia is prevalent and recurrent in HF patients, significantly impacting clinical outcomes.
• Reduced kidney function and spironolactone use are critical risk factors for hyperkalemia in HF.
• Effective management of hyperkalemia is crucial for improving survival and reducing healthcare utilization in HF patients.